Next Generation News and Research

RSS

Varian launches next generation dissolution apparatus

Varian, Inc. announced today the availability of its next generation dissolution apparatus designed for testing tablets, capsules and other dosage forms. The 708-DS supports a broad set of applications ranging from manual dissolution testing to automated, high-throughput analysis. It provides extensive flexibility to match the needs of individual laboratories, whether in research or testing. Integration with either the new Varian UV or LC Dissolution Systems will save time and reduce the potential for sample handling errors.

5 Mar 2010

Stryker Orthopaedics introduces ADM X3 Mobile Bearing Acetabular System for hip replacement surgery

Stryker Orthopaedics today announced the release of the ADM X3 Mobile Bearing Acetabular System, a next-generation technology for hip replacement surgery designed to minimize the risks associated with total hip replacement surgery.

From Stryker 5 Mar 2010

Bristol-Myers Squibb to review key accomplishments at meeting with investment community

During a meeting with the investment community today, Bristol-Myers Squibb Company will provide a comprehensive business overview, highlight positive pipeline developments and provide 2013 minimum non-GAAP earnings per share guidance.

5 Mar 2010

Patient enrollment in Phase II study of BioCart Autologous Cartilage System nearing halfway point

ProChon Biotech, Ltd., an innovator of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality-of-life for sufferers of articular cartilage injuries, today announced that patient enrollment in the Company’s Phase II study of the BioCart™ Autologous Cartilage System is nearing the halfway point and is expected to be completed within the next three months.

5 Mar 2010

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Watson Pharmaceuticals, Inc. today announced an agreement to expand their Women's Health brand product portfolio with the acquisition of the exclusive U.S. rights to Columbia Laboratories, Inc.'s bioadhesive progesterone gel products currently marketed under the trade names CRINONE® and PROCHIEVE® for the indications of infertility and secondary amenorrhea.

4 Mar 2010

Micromet reports total revenues of $4.6M for three months ended December 31, 2009

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the fourth quarter and full year ended December 31, 2009. The Company also highlighted recent pipeline progress and outlined expected 2010 milestones.

4 Mar 2010

Project ProSPECTus develops technology for next generation SPECT imaging to improve diagnosis of cancer

Time taken to detect brain tumours could soon be significantly reduced thanks to an ongoing pioneering project led by the University of Liverpool with the Nuclear Physics Group and Technology departments at the Science and Technology Facilities Council (STFC) at Daresbury Laboratory.

4 Mar 2010

ReShape Medical initiates IDE clinical study to assess effectiveness of dual-balloon device for weight loss

ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery.

4 Mar 2010

Children’s Mercy Hospitals and Clinics installs Infinix CF-i/BP vascular X-ray systems

To bring the latest in cardiovascular X-ray technology to its pediatric patients, Children’s Mercy Hospitals and Clinics in Kansas City, Mo., has installed two InfinixTM CF-i/BP vascular X-ray systems with 8" x 8" flat panel detectors (FPD) from Toshiba America Medical Systems, Inc. These systems are the first pediatric bi-plane systems in the U.S. equipped with Toshiba’s Next Generation Advanced Image Processing (AIP) capabilities.

3 Mar 2010

ASPEX to display game-changing PSEM eXpress analyzer at Pittcon 2010

ASPEX Corporation has been advancing the novel Personal Scanning Electron Microscope (PSEM) platform since its first product generation was released in 1992. Since then, it has been "shifting" where SEMs are traditionally installed, "shifting" when SEMs are utilized in industrial processes, and fundamentally "shifting" how SEMs are identified. Come experience the shift at Pittcon 2010, in Orlando, FL from March 1-4.

3 Mar 2010

Acuo Technologies granted patent covering technology implemented in DSG software suite

Acuo Technologies, the market leading Vendor Neutral Archive supplier, was granted US patent number 7,640,171 by the USPTO which covers technology implemented in its DICOM Services Grid™ software suite.

3 Mar 2010

GE Healthcare to showcase next-generation eHealth Solutions platform at 2010 HIMSS conference

GE Healthcare today announced the launch of its next-generation eHealth Solutions platform – an infrastructure offering that includes expanded services for health information exchange, a clinical portal and a patient health management system.

3 Mar 2010

EMA validates Lux Biosciences' voclosporin MAA

Isotechnika Pharma Inc. today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) filed by its partner, Lux Biosciences, Inc., for voclosporin. Following validation of the MAA, the dossier is distributed to members of the Committee for Medicinal Products for Human Use (CHMP) for formal review, which is expected to take one year.

2 Mar 2010

Cleveland HeartLab completes $3.0M fundraising round

Cleveland HeartLab LLC (CHL) today announced that it has completed a $3.0-million fundraising round. The company’s new shareholders include local business leaders, and Glengary LLC, Second Generation Ltd. and Zapis Capital Group LLC.

2 Mar 2010

St. Jude Medical's Trifecta valve receives CE Mark approval

St. Jude Medical, Inc. today announced that it has received CE Mark approval for the Trifecta™ valve, marking the Company’s launch into the market for pericardial aortic stented tissue valves.

2 Mar 2010

Primordial's platform and applications to be deployed at NYU Langone Medical Center

Primordial, a leading vendor of communication, workflow, quality management and analytics applications for the medical imaging market, announced today that it will deploy and further develop Primordial’s applications at NYU Langone Medical Center. As part of the agreement, Primordial will install its platform and applications at NYU Langone Medical Center, an integrated academic medical center, to unify communications and manage complex workflow for a highly sub-specialized and distributed work environment.

2 Mar 2010

Nuvon introduces IDM-MG 1000 portable solution for biomedical data collection

San Francisco-based Nuvon, Inc. (www.nuvon.com), a provider of next generation BMDI (biomedical device interoperability) solutions, announces the introduction of the IDM-MG 1000, extending Nuvon’s biomedical device interoperability capabilities by providing the first truly mobile and portable solution to collect and present critical biomedical device data anywhere.

2 Mar 2010

Loyola medical students and CRJHS students team up to promote healthcare awareness

Loyola University Chicago Stritch School of Medicine and Marcella Niehoff School of Nursing students are teaming up with high schoolers from Cristo Rey Jesuit High School (CRJHS) to bring awareness and share ideas about health care now and in the future.

2 Mar 2010

Life Technologies announces early stage results from SMS technology

Life Technologies Corporation today announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.

2 Mar 2010

AnaptysBio announces strategic collaboration to generate novel antibodies for specified disease target

AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced a strategic collaboration with an undisclosed leading global pharmaceutical company to generate novel antibody therapeutics to a specified disease target. This is the third collaboration with a leading pharmaceutical company announced by AnaptysBio during 2010.

1 Mar 2010

Next Generation News and Research

Varian launches next generation dissolution apparatus

Stryker Orthopaedics introduces ADM X3 Mobile Bearing Acetabular System for hip replacement surgery

Bristol-Myers Squibb to review key accomplishments at meeting with investment community

Patient enrollment in Phase II study of BioCart Autologous Cartilage System nearing halfway point

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Micromet reports total revenues of $4.6M for three months ended December 31, 2009

Project ProSPECTus develops technology for next generation SPECT imaging to improve diagnosis of cancer

ReShape Medical initiates IDE clinical study to assess effectiveness of dual-balloon device for weight loss

Children’s Mercy Hospitals and Clinics installs Infinix CF-i/BP vascular X-ray systems

ASPEX to display game-changing PSEM eXpress analyzer at Pittcon 2010

Acuo Technologies granted patent covering technology implemented in DSG software suite

GE Healthcare to showcase next-generation eHealth Solutions platform at 2010 HIMSS conference

EMA validates Lux Biosciences' voclosporin MAA

Cleveland HeartLab completes $3.0M fundraising round

St. Jude Medical's Trifecta valve receives CE Mark approval

Primordial's platform and applications to be deployed at NYU Langone Medical Center

Nuvon introduces IDM-MG 1000 portable solution for biomedical data collection

Loyola medical students and CRJHS students team up to promote healthcare awareness

Life Technologies announces early stage results from SMS technology

AnaptysBio announces strategic collaboration to generate novel antibodies for specified disease target

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News